ENTRADA THERAPEUTICS INC

Ticker: TRDA CUSIP: 29384C108 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,044,758 Value ($000) $10,740 Avg Close Range
Q3 2025
Shares 954,419 Value ($000) $5,536 Avg Close Range
Q2 2025
Shares 1,060,716 Value ($000) $7,128 Avg Close Range
Q1 2025
Shares 1,053,314 Value ($000) $9,522 Avg Close Range
Q4 2024
Shares 1,031,826 Value ($000) $17,840 Avg Close Range
Q3 2024
Shares 1,029,369 Value ($000) $16,449 Avg Close Range
Q2 2024
Shares 1,033,927 Value ($000) $14,733 Avg Close Range
Q1 2024
Shares 1,026,840 Value ($000) $14,550 Avg Close Range
Q4 2023
Shares 1,047,780 Value ($000) $15,811 Avg Close Range
Q3 2023
Shares 1,045,652 Value ($000) $16,521 Avg Close Range
Q2 2023
Shares 1,019,508 Value ($000) $15,435 Avg Close Range
Q1 2023
Shares 1,014,453 Value ($000) $14,710 Avg Close Range
Q4 2022
Shares 1,010,351 Value ($000) $13,660 Avg Close Range
Q3 2022
Shares 1,007,246 Value ($000) $15,874 Avg Close Range
Q2 2022
Shares 1,535,883 Value ($000) $18,707 Avg Close Range
Q1 2022
Shares 2,543,102 Value ($000) $23,816 Avg Close Range
Q4 2021
Shares 3,114,006 Value ($000) $52,797 Avg Close Range